Ikazia Ziekenhuis

At Ikazia Ziekenhuis in Rotterdam, clinical research in cardiology and metabolic disease focuses on conditions such as myocardial infarction, heart failure, atherosclerotic cardiovascular disease, obesity, and elevated lipoprotein(a). These studies are mainly designed to test new treatment approaches, reduce cardiovascular risk, and improve outcomes for patients with high-risk heart and vascular disease.

• New therapies for acute myocardial infarction and post-infarction recovery
• Risk-reduction strategies for atherosclerotic cardiovascular disease and related inflammation
• Treatment studies in heart failure with preserved or mildly reduced function
• Research on obesity-linked cardiovascular complications and lipid disorders

The site’s internal medicine team is contributing to trials that aim to improve long-term cardiovascular protection while also addressing inflammation and metabolic burden.

The hospital has an active program in cancer research, covering breast cancer, colorectal cancer, rectal cancer, gastric cancer, esophagogastric cancer, and blood cancers such as chronic lymphocytic leukemia, follicular lymphoma, marginal zone lymphoma, diffuse large B-cell lymphoma, and multiple myeloma. These trials are commonly aimed at improving treatment effectiveness, lowering recurrence risk, and refining care for patients with advanced or relapsed disease.

• Studies of new and combined treatments for breast cancer, including HER2-positive and triple-negative disease
• Research in colorectal and rectal cancer to improve disease-free and event-free survival
• Trials in lymphoma and chronic lymphocytic leukemia focused on disease control and deeper responses
• Studies in gastric and esophagogastric cancer exploring better treatment strategies for advanced disease

This research portfolio reflects a strong focus on both solid tumors and blood cancers, with several studies exploring ways to personalize treatment and reduce unnecessary toxicity.

Clinical trials at Ikazia Ziekenhuis also address respiratory tract diseases such as chronic obstructive pulmonary disease, pneumonia, influenza, and other viral respiratory infections. The main goal of this research is to improve symptom control, prevent worsening illness, and evaluate supportive treatments for hospitalized patients with serious lung infections.

• Treatment studies for COPD and prevention of exacerbations
• Hospital-based research in pneumonia and influenza
• Trials for severe respiratory virus infection in critically ill patients
• Studies aimed at improving recovery and reducing mortality in acute lung disease

The site’s work in this area combines infection management with broader efforts to improve outcomes in patients admitted with serious breathing-related illness.

Research in digestive system disease and immune-mediated conditions includes Crohn’s disease, ulcerative colitis, obesity, and related metabolic concerns. These studies are designed to assess new treatment combinations, improve remission rates, and better address the overlap between inflammatory bowel disease and weight-related health problems.

• Trials in Crohn’s disease and ulcerative colitis focused on disease control
• Research combining inflammation management with metabolic care
• Studies looking at symptom relief and sustained clinical remission
• Work aimed at improving quality of life in chronic digestive disease

This area highlights the site’s interest in integrated care for patients whose gastrointestinal disease is closely linked with broader metabolic health.

The site is involved in trials on hormonal diseases, female urogenital conditions, and reproductive health, including Graves’ disease, polycystic ovary syndrome, vasomotor symptoms, and fertility-related care. The purpose of this research is to improve symptom management, support hormonal balance, and evaluate better options for women’s health and endocrine disorders.

• Studies in Graves’ disease focused on better control of thyroid autoimmunity
• Research on polycystic ovary syndrome and ovulation induction
• Trials addressing vasomotor symptoms linked to breast cancer treatment
• Work to improve care in female reproductive and urinary health conditions

These studies show a broad interest in endocrine and reproductive medicine, with attention to both symptom relief and longer-term health outcomes.

Another important research area at Ikazia Ziekenhuis is the study of serious bacterial and viral infections, including Staphylococcus aureus bacteremia, sepsis, and other severe hospital-acquired or community-acquired infections. These trials aim to improve survival, refine supportive care, and strengthen treatment strategies for acutely ill patients.

• Research on sepsis and intensive care treatment approaches
• Studies of Staphylococcus aureus bacteremia to improve short-term outcomes
• Trials addressing serious bacterial infections and infection-related complications
• Hospital-based work on better care for patients with acute infectious illness

This reflects a practical focus on high-impact infections where better treatment decisions can quickly influence patient recovery.

The research portfolio also includes studies in venous thromboembolism, diabetic ischemic ulcers, and other vascular complications. These trials are generally aimed at preventing recurrence, reducing serious complications, and improving healing and safety in patients with complex medical conditions.

• Trials to prevent and treat venous thromboembolism in patients with cancer
• Research on ischemic diabetic ulcers and wound healing
• Studies focused on reducing major complications in patients with vascular disease
• Supportive care approaches for complex chronic illness

Together, these studies add an important prevention-oriented dimension to the site’s internal medicine research.